{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:59:19Z","timestamp":1781175559984,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T00:00:00Z","timestamp":1647734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/50945-4"],"award-info":[{"award-number":["2014\/50945-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/22888-4"],"award-info":[{"award-number":["2017\/22888-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/07534-4"],"award-info":[{"award-number":["2018\/07534-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejps.2022.106173","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T21:39:28Z","timestamp":1647898768000},"page":"106173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pharmacokinetic study of AmB-NP-GR: A new granule form with amphotericin B to treat leishmaniasis and fungal infections"],"prefix":"10.1016","volume":"173","author":[{"given":"Maraine Catarina","family":"Tadini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9057-351X","authenticated-orcid":false,"given":"Fernanda Santos","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saulo Duarte","family":"Ozelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Reis Santos","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luiza","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6880-2315","authenticated-orcid":false,"given":"Tha\u00eds Bueno","family":"de Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1823-1184","authenticated-orcid":false,"given":"Nayara Cristina Perez","family":"de Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Crispim","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5156-8953","authenticated-orcid":false,"given":"Franciane","family":"Marquele-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5305-8957","authenticated-orcid":false,"given":"Anderson Rodrigo Moraes","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106173_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/pharmaceutics6010137","article-title":"Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology","volume":"6","author":"Ait-Oudhia","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2022.106173_bib0002","unstructured":"ANVISA, 2017. RDC 166\/2017. Brazilian Health Regulatory Agency. http:\/\/antigo.anvisa.gov.br\/documents\/10181\/2721567\/RDC_166_2017_COMP.pdf\/d5fb92b3-6c6b-4130-8670-4e3263763401 (accessed 10 May 2020)."},{"key":"10.1016\/j.ejps.2022.106173_bib0003","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","author":"Brunton","year":"2017"},{"key":"10.1016\/j.ejps.2022.106173_bib0004","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2022.106173_bib0005","first-page":"354","article-title":"Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module","volume":"6","author":"Chaudhari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2022.106173_bib0006","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/bdd.2510160604","article-title":"Pharmacokinetics of amphotericin B in rats as a function of dose following constant-rate intravenous infusion","volume":"16","author":"Chow","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2022.106173_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080411","article-title":"Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches","volume":"11","author":"Dahlgren","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2022.106173_bib0008","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jchromb.2009.11.036","article-title":"Determination of free and liposomal amphotericin B in human plasma by liquid chromatography-mass spectroscopy with solid phase extraction and protein precipitation techniques","volume":"878","author":"Deshpande","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2022.106173_bib0009","first-page":"1","year":"2012","journal-title":"Guideline on Bioanalytical Method Validation"},{"key":"10.1016\/j.ejps.2022.106173_bib0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.35.6.1208","article-title":"Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats","volume":"35","author":"Fielding","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106173_bib0011","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/dkp140","article-title":"Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation","volume":"64","author":"Gershkovich","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2022.106173_bib0012","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1093\/cid\/ciz076","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B","volume":"68","author":"Groll","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2022.106173_bib0013","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2022.106173_bib0014","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1211\/0022357022502","article-title":"Disposition of amphotericin B in the isolated perfused rat liver","volume":"56","author":"Hong","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2022.106173_bib0015","series-title":"Comprehensive Medicinal Chemistry III","article-title":"Drug classification and drug disposition prediction","author":"Hosey","year":"2017"},{"key":"10.1016\/j.ejps.2022.106173_bib0016","article-title":"Physical characterization of multiparticulate systems","volume":"53","author":"Issa","year":"2017","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106173_bib0017","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","article-title":"Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous fungizone\u00ae","volume":"26","author":"Italia","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106173_bib0018","first-page":"2733","article-title":"Advanced drug delivery to the lymphatic system: lipid-based nanoformulations","volume":"8","author":"Khan","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2022.106173_bib0019","doi-asserted-by":"crossref","unstructured":"Kwon, M.H., Jeong, J.S., Ryu, J., Cho, Y.W., Kang, H.E., 2018. Pharmacokinetics and brain distribution of the active components of DA-9805, Saikosaponin A, paeonol, and imperatorin in rats. 10.3390\/pharmaceutics10030133.","DOI":"10.3390\/pharmaceutics10030133"},{"key":"10.1016\/j.ejps.2022.106173_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9040041","article-title":"Predicting oral drug absorption: mini review on physiologically-based pharmacokinetic models","volume":"9","author":"Lin","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2022.106173_bib0021","first-page":"916","article-title":"Methodology development and validation of amphotericin B stability by HPLC\u2011DAD","volume":"31","author":"Montenegro","year":"2020","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejps.2022.106173_bib0022","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jvp.12709","article-title":"Application of different pharmacokinetic models to describe and predict pharmacokinetics of voriconazole in magellanic penguins following oral administration","volume":"42","author":"Parsley","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2022.106173_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-19867-0","article-title":"Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in a silkworm infection model","volume":"8","author":"Paudel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2022.106173_bib0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/10717544.2016.1228715","article-title":"Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats","volume":"24","author":"Radwan","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2022.106173_bib0025","article-title":"Correction to: efficient antileishmanial activity of amphotericin B and piperine entrapped in enteric coated guar gum nanoparticles (drug delivery and translational research","author":"Ray","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2022.106173_bib0026","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","article-title":"Applications of nanoparticle systems in drug delivery technology","volume":"26","author":"Rizvi","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejps.2022.106173_bib0027","first-page":"11","article-title":"Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis","volume":"10","author":"Shirzadi","year":"2019","journal-title":"Res. Rep. Trop. Med. Vol."},{"key":"10.1016\/j.ejps.2022.106173_bib0028","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2022.106173_bib0029","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jpba.2017.06.034","article-title":"Method validation and nanoparticle characterization assays for an innovative amphothericin B formulation to reach increased stability and safety in infectious diseases","volume":"145","author":"Tadini","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2022.106173_bib0030","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1337-8","article-title":"Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability","volume":"20","author":"Talegaonkar","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2022.106173_bib0031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09205063.2019.1680926","article-title":"Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats","volume":"31","author":"Tan","year":"2020","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ejps.2022.106173_bib0032","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/jphp.12802","article-title":"Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis","volume":"69","author":"Tonin","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2022.106173_bib0033","first-page":"1","article-title":"crossm following single- and multiple-dose administration to","volume":"64","author":"Wasan","year":"2020","journal-title":"Beagle"},{"key":"10.1016\/j.ejps.2022.106173_bib0034","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/AAC.00265-11","article-title":"Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipients","volume":"56","author":"W\u00fcrthwein","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106173_bib0035","series-title":"Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice: Second Edition","article-title":"Process development, optimization, and scale-up: fluid-bed granulation","author":"Yamamoto","year":"2017"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722000586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722000586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:56:23Z","timestamp":1778558183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":35,"alternative-id":["S0928098722000586"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106173","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic study of AmB-NP-GR: A new granule form with amphotericin B to treat leishmaniasis and fungal infections","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106173"}}